SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-067797
Filing Date
2024-06-03
Accepted
2024-06-03 16:21:04
Documents
8
Period of Report
2024-06-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2416228d1_def14a.htm DEF 14A 725932
2 GRAPHIC image_003.jpg GRAPHIC 28846
3 GRAPHIC image_004.jpg GRAPHIC 28105
4 GRAPHIC tm2416228d1_def14aimg003.jpg GRAPHIC 8153
5 GRAPHIC tm2416228d1_def14aimg004.jpg GRAPHIC 8153
6 GRAPHIC tm2416228d1_def14aimg005.jpg GRAPHIC 97910
7 GRAPHIC tm2416228d1_def14img001.jpg GRAPHIC 180751
8 GRAPHIC tm2416228d1_def14img002.jpg GRAPHIC 189288
  Complete submission text file 0001104659-24-067797.txt   1473533
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: DEF 14A | Act: 34 | File No.: 001-36288 | Film No.: 241013854
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)